A New Target for Late-Life Depression Offers Hope for Chronic Pain Sufferers
A randomized, sham-controlled clinical trial published in the American Journal of Psychiatry has demonstrated the efficacy of bilateral theta-burst stimulation (TBS) of the dorsolateral prefrontal cortex for treating late-life depression. This non-invasive neuromodulation technique, a form of repetitive transcranial magnetic stimulation, showed significant antidepressant effects compared to a sham procedure. The findings are critical for pain medicine as depression and chronic pain, including conditions like fibromyalgia and neuropathic pain, share overlapping neural circuits and are frequently comorbid. The dorsolateral prefrontal cortex is a key node in networks involved in both mood regulation and the cognitive-evaluative aspects of pain perception, including pain catastrophizing.
Study Significance: For clinicians managing complex chronic pain, this research validates a non-pharmacological, interventional tool that can address the significant depressive component often complicating treatment. It suggests that neuromodulation strategies effective for mood disorders may have direct or adjunctive applications in pain conditions characterized by central sensitization. This advances the paradigm of multimodal analgesia, integrating neurostimulation with behavioral and pharmacological therapies to improve functional restoration in patients with refractory pain and comorbid depression.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
